 |
|
Pharmacokinetics of tacrolimus according to body composition in recipients of kidney transplants
Seung Seok Han, Do Hyoung Kim, Su Mi Lee, Na Young Han, Jung Mi Oh, Jongwon Ha, Yon Su Kim
Kidney Res Clin Pract. 2012;31(3):157-162. Published online 2012 Jun 26 DOI: https://doi.org/10.1016/j.krcp.2012.06.007
|
|
Citations to this article as recorded by
 A pharmacist-led intervention to improve kidney transplant recipient outcomes and identify patients at risk of highly variable trough tacrolimus levels: a cohort study
Roxane Lhermitte, Brendan Le Daré, Florian Laval, Florian Lemaitre, Barbara Troussier, Marie-Pascale Morin, Cécile Vigneau, Jonathan M Chemouny, Astrid Bacle
European Journal of Hospital Pharmacy.2024; 31(4): 314. CrossRef Tumorigenic role of tacrolimus through mTORC1/C2 activation in post-transplant renal cell carcinomas
Dorottya Moldvai, Dániel Sztankovics, Titanilla Dankó, Enikő Vetlényi, Gábor Petővári, Ágnes Márk, Attila Patonai, Gyula Végső, László Piros, Ádám Hosszú, Judit Pápay, Ildikó Krencz, Anna Sebestyén
British Journal of Cancer.2024; 130(7): 1119. CrossRef Dietary Influence on Drug Efficacy: A Comprehensive Review of Ketogenic Diet–Pharmacotherapy Interactions
Simona Cristina (Nicolescu) Marinescu, Miruna-Maria Apetroaei, Marina Ionela (Ilie) Nedea, Andreea Letiția Arsene, Bruno Ștefan Velescu, Sorina Hîncu, Emilia Stancu, Anca Lucia Pop, Doina Drăgănescu, Denisa Ioana Udeanu
Nutrients.2024; 16(8): 1213. CrossRef Physiologically-based pharmacokinetic modelling to investigate the effect of CYP3A4/3A5 maturation on tacrolimus pharmacokinetics in paediatric HSCT patients
Yanping Guan, Xiaolin Liu, Ke Huang, Ying Wang, Kaifeng Qiu, Xueding Wang, Min Huang, Dunhua Zhou, Xiaoxia Yu, Guoping Zhong
European Journal of Pharmaceutical Sciences.2024; 201: 106839. CrossRef The Relationship Between Weight Indices and Blood Levels of Immunosuppressive Drugs in Renal Transplant Recipients
Shirinsadat Badri, Bozorgmehr Dadkhah-Tehrani, Abdolamir Atapour, Shahrzad Shahidi, Mojgan Mortazavi, Tahereh Gholipourshahraki
Iranian Journal of Pharmaceutical Research.2024;[Epub] CrossRef Tacrolimus- and Mycophenolate-Mediated Toxicity: Clinical Considerations and Options in Management of Post-Transplant Patients
Alan D. Kaye, Shivam S. Shah, Coplen D. Johnson, Adalyn S. De Witt, Austin S. Thomassen, Charles P. Daniel, Shahab Ahmadzadeh, Sridhar Tirumala, Kristin Nicole Bembenick, Adam M. Kaye, Sahar Shekoohi
Current Issues in Molecular Biology.2024; 47(1): 2. CrossRef A Prospective Study to Assess the Best Optimal Dose of Tacrolimus before Renal Transplantation and Its Impact on Graft Survival and Patient Outcome in Renal Transplant Recipients
Niranjan Gogoi, Charu Jain, Megha Agarwal, Dhananjay Agarwal, Ajay Gupta, Munesh Kumar
Indian Journal of Transplantation.2024; 18(4): 367. CrossRef Effect of tacrolimus with mycophenolate mofetil or cyclophosphamide on the renal response in systemic lupus erythematosus patients
Siqin Sun, Xueyi Zhang, Qingqing Guo, Xiaojun Tang, Wei Shen, Jun Liang, Genhong Yao, Linyu Geng, Shuai Ding, Hongwei Chen, Hong Wang, Bingzhu Hua, Huayong Zhang, Xuebing Feng, Ziyi Jin, Lingyun Sun
BMC Rheumatology.2024;[Epub] CrossRef Retrospective evaluation of LCP‐tacrolimus (Envarsus XR) dosing in de novo kidney transplant
Mohammed Alzahrani, Rachel M. Belcher, Jamie Benken, Benito Valdepenas, Pierpaolo Di Cocco, Mathula Kajavathanan, Scott T. Benken
Clinical Transplantation.2023;[Epub] CrossRef CYP3A5*3 and CYP3A4*22 Cluster Polymorphism Effects on LCP-Tac Tacrolimus Exposure: Population Pharmacokinetic Approach
Zeyar Mohammed Ali, Marinda Meertens, Beatriz Fernández, Pere Fontova, Anna Vidal-Alabró, Raul Rigo-Bonnin, Edoardo Melilli, Josep M. Cruzado, Josep M. Grinyó, Helena Colom, Nuria Lloberas
Pharmaceutics.2023; 15(12): 2699. CrossRef Pharmacokinetics of tacrolimus following an overdose in a patient with extreme obesity and genotype CYP3A5*3/*3: a case report
Toshinori Hirai, Yoshihiko Morikawa, Noriko Sasaki, Hideo Kato, Daisuke Nakato, Masahiro Hirayama, Tadashi Kaneko, Hiroshi Imai, Takuya Iwamoto
The Journal of Toxicological Sciences.2022; 47(2): 71. CrossRef Body composition is associated with tacrolimus pharmacokinetics in kidney transplant recipients
M. I. Francke, W. J. Visser, D. Severs, A. M. E. de Mik - van Egmond, D. A. Hesselink, B. C. M. De Winter
European Journal of Clinical Pharmacology.2022; 78(8): 1273. CrossRef Implications for body weight extremes in solid organ transplantation
Maya Campara, Laura M. Lourenco, Jennifer I. Melaragno, Tiffany E. Kaiser
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.2021; 41(1): 44. CrossRef Calcineurin and Systemic Lupus Erythematosus: The Rationale for Using Calcineurin Inhibitors in the Treatment of Lupus Nephritis
Carlos Rafael-Vidal, Irene Altabás, Nair Pérez, Coral Mourino Rodríguez, Jose M. Pego-Reigosa, Samuel Garcia
International Journal of Molecular Sciences.2021; 22(3): 1263. CrossRef Tacrolimus Exposure in Obese Patients: and A Case–Control Study in Kidney Transplantation
Vincent Robert, Emmanuelle Manos-Sampol, Thibaut Manson, Thomas Robert, Nicolas Decourchelle, Anne-Sophie Gruliere, Sylvie Quaranta, Valérie Moal, Tristan Legris
Therapeutic Drug Monitoring.2021; 43(2): 229. CrossRef The Relationship between Initial Tacrolimus Metabolism Rate and Recipients Body Composition in Kidney Transplantation
Aureliusz Kolonko, Patrycja Pokora, Natalia Słabiak-Błaż, Beata Czerwieńska, Henryk Karkoszka, Piotr Kuczera, Grzegorz Piecha, Andrzej Więcek
Journal of Clinical Medicine.2021; 10(24): 5793. CrossRef Understanding and Preventing Adverse Effects of Tacrolimus Metabolization in Transplant Patients
Eleonore Fröhlich
Current Drug Metabolism.2020; 20(13): 1039. CrossRef Dosing algorithm for Tacrolimus in Tunisian Kidney transplant patients: Effect of CYP 3A4*1B and CYP3A4*22 polymorphisms
Nadia Ben-Fredj, Ibtissem Hannachi, Zohra Chadli, Haifa Ben-Romdhane, Naceur A Boughattas, Najah Ben-Fadhel, Karim Aouam
Toxicology and Applied Pharmacology.2020; 407: 115245. CrossRef Impact of body composition on pharmacokinetics of tacrolimus in liver transplantation recipients
Lu Chen, Xiaoqing Lu, Guijun Tan, Liqin Zhu, Yihe Liu, Mengxue Li
Xenobiotica.2020; 50(2): 196. CrossRef Weight‐based tacrolimus trough concentrations post liver transplant
Zheng Liu, Jeffrey Cheng, Elizabeth Powell, Graeme Macdonald, Jonathan Fawcett, Stephen Lynch, Jennifer Martin
Internal Medicine Journal.2019; 49(1): 79. CrossRef Personalized immunosuppression in elderly renal transplant recipients
L.E.J. Peeters, L.M. Andrews, D.A. Hesselink, B.C.M. de Winter, T. van Gelder
Pharmacological Research.2018; 130: 303. CrossRef Which Kidney Transplant Recipients Can Benefit from the Initial Tacrolimus Dose Reduction?
Kinga Krzyżowska, Aureliusz Kolonko, Piotr Giza, Jerzy Chudek, Andrzej Więcek
BioMed Research International.2018; 2018: 1. CrossRef Understanding alterations in drug handling with aging
Steven Gabardi, Stefan G. Tullius, Felix Krenzien
Current Opinion in Organ Transplantation.2015; 20(4): 424. CrossRef
|